Human Prostate Cancer-Associated Endothelial Cells
Quick Actions
Product Overview
Description
Prostate Cancer is one of the most frequently diagnosed cancers and a leading cause of cancer-related death in men worldwide. Central to its progression is the tumor microenvironment (TME), a complex ecosystem that drives tumor growth, metastasis, and treatment resistance. Among the key cellular constituents of the TME are cancer-associated endothelial cells (CAECs) vascular endothelial cells that line tumor blood vessels and play a far more active role in cancer progression than previously understood.
Guarantee expansion for a minimum of 2-5 population
doublings.
IMPORTANT: Quality warranty requires use of NeoBioPharma media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.
Key Features
Catalog Number: NBPCAE009
Product Format: Frozen
Vial Cell Number: > 5x10[5] cells/vial
Passage:1(P1)
Storage: Liquid Nitrogen, Vapor Phase
Intended Use: Research use only (RUO)
Characterization Markers
Positive for endothelial cell markers such as CD31 (PECAM-
1) and VE-Cadherin, as verified by immunofluorescence staining or flow cytometry (FACS). Uptake of DiI-Ac-LDL (acetylated low-density lipoprotein) as a functional marker .
Quick Facts
Product Type
Human Cancer Associated Endothelial Cells
Viability
>95% viable (Trypan Blue exclusion)
Applications
Research & Development
Availability
In Stock • Global Shipping
Technical Specifications
Applications & Use Cases
Research Areas
In Vitro Studies
Cell culture and screening applications
Molecular Biology
Gene expression & signaling studies
Drug Discovery
Screening & validation studies
Disease Modeling
Pathophysiology research
Support & Resources
Technical Support
Our experts are available for technical questions and protocol assistance.
Contact Support
